Gerald K. Bayer works in the field of Oncology. He attended University of Wisconsin School of Medicine and Public Health. He over the years received 1 awards: "Meaningful Use Stage 1 Certification". Gerald Bayer has written publications. He has 1 publication published with PubMed. The lastest publication is: 'A phase II trial of triapine (NSC# 663249) and gemcitabine as second line treatment of advanced non-small cell lung cancer: Eastern Cooperative Oncology Group Study 1503.'
![]() |
Patti M. Marquardt, NP
![]() |
![]() |
Dr. Umang Gautam, MD
![]() |
![]() |
Dr. Kevin L. Mortara, MD
![]() |
![]() |
Dr. David L. Groteluschen, MD
![]() |
![]() |
Dr. Hassan I. Tahsildar, MD
![]() ![]() |
![]() |
Dr. Nancy B. Davis, MD |
![]() |
Dr. Nathan D. Munson, MD
![]() |
![]() |
Dr. Patrick J. Mansky, MD
![]() ![]() |
![]() |
Dr. Ernest C. Lewis, MD |